Shandong Buchang Pharmaceuticals Co Ltd (603858) — Cash Flow-to-Debt Ratio
Shandong Buchang Pharmaceuticals Co Ltd (603858) has a Cash Flow-to-Debt Ratio of -0.02x as of September 2025, meaning its operating cash flow of CN¥-145.26 Million could theoretically repay 0% of its total liabilities (CN¥9.50 Billion) in one year. Check Shandong Buchang Pharmaceuticals Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shandong Buchang Pharmaceuticals Co Ltd Cash Flow-to-Debt Ratio (2011–2024)
Historical debt coverage capacity for Shandong Buchang Pharmaceuticals Co Ltd across 14 annual periods. Also explore 603858 asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Shandong Buchang Pharmaceuticals Co Ltd (2011–2024)
Year-by-year debt coverage analysis for Shandong Buchang Pharmaceuticals Co Ltd. For market capitalisation and broader financial context, see Shandong Buchang Pharmaceuticals Co Ltd (603858) total market value.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.10x | CN¥939.95 Million | CN¥9.52 Billion | ▲ +672.0% |
| 2023 | -0.02x | CN¥-164.26 Million | CN¥9.52 Billion | ▼ -106.1% |
| 2022 | 0.28x | CN¥2.76 Billion | CN¥9.68 Billion | ▲ +105.6% |
| 2021 | 0.14x | CN¥1.32 Billion | CN¥9.54 Billion | ▼ -35.8% |
| 2020 | 0.22x | CN¥1.96 Billion | CN¥9.08 Billion | ▼ -39.1% |
| 2019 | 0.35x | CN¥2.62 Billion | CN¥7.40 Billion | ▲ +6.5% |
| 2018 | 0.33x | CN¥2.05 Billion | CN¥6.17 Billion | ▲ +1.3% |
| 2017 | 0.33x | CN¥1.96 Billion | CN¥5.98 Billion | ▲ +17.2% |
| 2016 | 0.28x | CN¥1.67 Billion | CN¥5.96 Billion | ▲ +12.3% |
| 2015 | 0.25x | CN¥2.12 Billion | CN¥8.50 Billion | ▼ -34.8% |
| 2014 | 0.38x | CN¥1.78 Billion | CN¥4.65 Billion | ▼ -8.8% |
| 2013 | 0.42x | CN¥1.11 Billion | CN¥2.66 Billion | ▼ -48.8% |
| 2012 | 0.82x | CN¥1.35 Billion | CN¥1.65 Billion | ▼ -13.4% |
| 2011 | 0.95x | CN¥1.55 Billion | CN¥1.64 Billion | — |